Company intelligence / Profile preview

Roka Bioscience

Lake Forest Park, Washington, United Statesrokabio.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Roka Bioscience developed and commercialized rapid molecular assays and instrument systems for detecting foodborne pathogens using nucleic acid-based technologies. Its flagship product was the fully automated Atlas System for high-throughput pathogen detection in various foods. The company’s technology targeted ribosomal RNA to deliver sensitive results with reduced enrichment times.

Modalities: Molecular assayNucleic acid test (NAT)
Industry: Molecular Diagnostics

Partnerships

Exclusive licensing rights from Hologic/Gen-Probe for core technologies

Beyond the preview

Go deeper on Roka Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Roka Bioscience.

Explore the full profile